MEQUON, Wis., July 15, 2026 /PRNewswire/ -- Vector Science & Therapeutics, Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced the expansion of its intellectual property portfolio to 15 ...
Vector Science & Therapeutics (PAIN.V) plans to build a distributor network to support the commercialization of its peptide portfolio, the company said Tuesday. Peptides are short-chain amino acids ...
Company's expanding IP estate is led by multiple pending applications in peptide and biologic delivery, alongside advanced drug delivery, opioid-sparing pain management, pancreatic oncology, ...